4 results about "GLYCERYL PALMITATE" patented technology

This invention discloses a bone hemostatic and repair material, its preparation method, and its application, belonging to the field of medical materials technology. The bone hemostatic and repair material provided by this invention comprises the following raw materials: organic ester compounds, organic acids, and borosilicate bioglass; the organic acids include at least one selected from oleic acid, linoleic acid, palmitic acid, and lauric acid; the organic ester compounds include at least one selected from palmitic acid glyceride, oleic acid glyceride, monolauric acid glyceride, and dilauric acid glyceride. The bone hemostatic and repair material proposed in this invention can effectively stop bleeding, and can also be absorbed by the body after surgery while promoting bone tissue healing, reducing adverse reactions and complications. This invention also discloses the preparation method and application of the above-mentioned bone hemostatic and repair material.

The invention belongs to the technical field of pharmaceutical preparations, and particularly discloses an anti-schizophrenia lyotropic liquid crystal long-acting injection and a preparation method and application thereof, and the anti-schizophrenia lyotropic liquid crystal long-acting injection is composed of an anti-schizophrenia drug, an amphiphilic compound and an organic solvent; the anti-schizophrenia medicine is selected from any one of brexpiprazole, cariprazine and aripiprazole; the amphiphilic compound is selected from any one or more of soybean phosphatidylcholine, egg yolk phosphatidylcholine, glyceryl monooleate, glyceryl monopalmitate, glyceryl dioleate, glyceryl trioleate, vitamin E acetate and phytantriol; the organic solvent is selected from one or more of ethanol, N-methyl pyrrolidone, dimethyl sulfoxide and 1, 2-propylene glycol. The anti-schizophrenia lyotropic liquid crystal in-situ gel long-acting injection forms a stable semi-solid drug reservoir through solvent exchange after administration so as to play a therapeutic effect in long-acting treatment of positive schizophrenia and negative schizophrenia and prevention of schizophrenia relapse.

An artificial hair fiber comprising a synthetic resin fiber; and one or more compounds selected from the group consisting of palmitic acid, a palmitate, palmitic acid glyceride, stearic acid, a stearate, and stearic acid glyceride, adhering to the synthetic resin fiber, wherein a total content of the compound is 0.05 wt % or more and less than 0.15 wt % based on a total amount of the artificial hair fiber.

This document provides compositions comprising (or consisting essentially of or consisting of) one or more water-soluble oils selected from the group consisting of ethoxylated macadamia oil, ethoxylated olive oil, ethoxylated avocado oil, ethoxylated meadowfoam oil, ethoxylated almond oil, ethoxylated corn oil, ethoxylated soybean oil, ethoxylated jojoba oil, ethoxylated seabuckthorn oil (e.g., fruit, berry, or seed oil), ethoxylated emu oil, ethoxylated mink oil, PEG Glyceryl Dimyristate, PEG Glyceryl Dioleate, PEG Glyceryl Distearate, and PEG Glyceryl Palmitate; and one or more agricultural chemical or biological agents. Methods for making and using the compositions also are provided.